TY - JOUR
TI - Meningococcal serogroup Y emergence in Europe High importance in some
European regions in 2012
AU - Broeker, Michael
AU - Bukovski, Suzana
AU - Culic, Davor
AU - Jacobsson,
AU - Susanne
AU - Koliou, Maria
AU - Kuusi, Markku
AU - Simoes, Maria Joao and
AU - Skoczynska, Anna
AU - Toropainen, Maija
AU - Taha, Muhamed-Keir and
AU - Tzanakaki, Georgina
JO - Human Vaccines & Immunotherapeutics
PY - 2014
VL - 10
TODO - 6
SP - 1725-1728
PB - Landes Bioscience
SN - 2164-5515, 2164-554X
TODO - 10.4161/hv.28206
TODO - epidemiology; Europe; invasive meningococcal disease; serogroup Y;
meningococcal vaccines; surveillance
TODO - Neisseria meningitidis is differentiated into 12 distinct serogroups, of
which A, B, C, W, X, and Y are medically most important and represent an
important health problem in different parts of the world. The
epidemiology of N. meningitidis is unpredictable over time and across
geographic regions. Recent epidemiological surveillance has indicated an
increase of serogroup Y invasive meningococcal disease in some parts of
Europe as shown in the epidemiological data for 2010 and 2011 from
various European countries previously published in this journal. 1,2
Here, data from 33 European countries is reported indicating that the
emergence of serogroup Y continued in 2012 in various regions of Europe,
especially in Scandinavia, while in Eastern and South-Eastern Europe the
importance of serogroup Y remained low.
ER -